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Comparative genomics
SequencingAnalyses of turkey coronavirus (TCoV), an enteric disease virus that is highly similar to infectious bronchitis
virus (IBV) an upper-respiratory tract disease virus in chickens, were conducted to determine the adaptive
potential, and genetic changes associated with emergence of this group 3 coronavirus. Strains of TCoV that
were pathogenic in poults and nonpathogenic in chickens did not adapt to cause disease in chickens.
Comparative genomics revealed two recombination sites that replaced the spike gene in IBV with an
unidentiﬁed sequence likely from another coronavirus, resulting in cross-species transmission and a
pathogenicity shift. Following emergence in turkeys, TCoV diverged to different serotypes through the
accumulation of mutations within spike. This is the ﬁrst evidence that recombination can directly lead to the
emergence of new coronaviruses and new coronaviral diseases, emphasizing the importance of limiting
exposure to reservoirs of coronaviruses that can serve as a source of genetic material for emerging viruses.
© 2009 Elsevier Inc. All rights reserved.Introduction
Coronaviruses are worldwide in distribution, highly infectious, and
extremely difﬁcult to control. They can cause respiratory, enteric, and
in some cases hepatic and neurological diseases in a wide variety of
animals and in humans. Three groups have historically been
recognized based on antigenic and genetic characteristics. However,
after the emergence of severe acute respiratory syndrome coronavirus
(SARS-CoV), the group 2 coronaviruses were split into subgroup 2a
containing previously recognized group 2 viruses and subgroup 2b
containing SARS-CoV (Gorbalenya et al., 2004). Studies to identify the
animal reservoir for SARS-CoV led to the discovery of a diverse
population of coronaviruses related to groups 1 and 2 in bats
(Chiroptera) (Vijaykrishna et al., 2007; Woo et al., 2006).
Coronaviruses similar to the group 3 coronaviruses, which include
the avian coronaviruses infectious bronchitis virus (IBV) and turkey
coronavirus (TCoV), have been found in a variety of avian species
including thrush (Turdus spp.), munia (Lonchura spp.), bulbul
(Hypsipetes spp.), teal (Anas crecca), duck (Anseriformes), pigeon
(Columbiformes), peafowl (Galliformes), pheasant (Galliformes), red
knot (Calidris canutus), goose (Anserinae), and whooper swan (Cygnusd).
ll rights reserved.cygnus) as well as in a beluga whale (Delphinapterus leucas)
(Cavanagh et al., 2002; Hughes et al., 2009; Jonassen et al., 2005;
Liu et al., 2005; Mihindukulasuriya et al., 2008; Muradrasoli et al.,
2009;Woo et al., 2009b). These novel group 3 coronaviruses led to the
proposal of subgroups 3a, 3b, and 3c (Woo et al., 2009b). Group 3-
related viruses have also been found in an Asian leopard cat
(Prionailurus bengalensis) and Chinese ferret badgers (Melogale
moschata), but not in bats (Dong et al., 2007; Woo et al., 2006). It
was suggested that wild bird species are the reservoir for the group 3
coronaviruses, which are primarily avian in origin, whereas bats are
the reservoir for the group 1 and 2mammalian coronaviruses (Woo et
al., 2009a). This observation ﬁts well with the view that, in addition to
close contact, RNA viruses more readily undergo cross-species
transmission when the two host species are closely related (Holmes
and Rambaut, 2004). These studies indicate that an enormous,
previously unrecognized reservoir for coronaviruses exists among
animals, which is not unlike the reservoir that exists for inﬂuenza
viruses in animals.
Coronavirus diversity is due to adaptive evolution driven by high
mutation rates and genetic recombination (Holmes, 2009). Given the
vast capacity for coronaviruses to change, it is not surprising that host
switching leading to new diseases has occurred among coronaviruses
(Li et al., 2005; Rest and Mindell, 2003; Stavrinides and Guttman,
2004; Woo et al., 2009a; Zhang et al., 2005), most notably the abrupt
Table 2
Pathogenicity of TCoV in 1-day-old turkeys.
Virus No. with lesions/total examined
24 h PIa 48 h PI 72 h PI 96 h PI
TCoV/VA-74/03 0/4 3/4 (13.7) 4/4 4/4
TCoV/TX-GL/01 0/4 2/4 (15.4) 3/4 4/4
TCoV/IN-517/94 0/4 0/4 (13.9) 4/4 4/4
TCoV/TX-1038/98 0/4 (21.7)b 1/4 (16.7) 3/4 (20.1) 4/4 (37.6)
a PI=post-inoculation.
b Real-time RT-PCR cycle threshold value.
99M.W. Jackwood et al. / Virology 398 (2010) 98–108emergence of SARS-CoV in people in southern China in 2002, which
quickly spread to 27 countries (including the United States) and
resulted in 8096 cases and 744 deaths (http://www.who.int/csr/
sars/country/table2004_04_21/en/index.html). However, recombi-
nation events in coronaviruses are not thought to play a key role in
cross-species transmission since it appears that recombination events
in the SARS-CoV occurred prior to the jump into humans (Hon et al.,
2008). Rather, the emergence of new coronaviruses and coronaviral
diseases are believed to be due to adaptive evolution (Holmes and
Rambaut, 2004).
Previously unrecognized coronaviruses have emerged in animals.
In 1995, a coronavirus was isolated from the enteric tract of turkeys
with diarrhea in North Carolina and quickly spread throughout
commercial turkeys in the USA (Guy, 2008). That virus was found to
be similar to IBV based on cross-reactive antibodies (Guy, 2000). IBV
causes a highly contagious upper-respiratory tract disease in chickens
and is not known to infect or cause disease in turkeys (Cavanagh and
Gelb, 2008). Several studies conducted on various TCoV isolates
showed that the order of the genes at the 3′ end of the genome was
similar to IBV (Breslin et al., 1999; Cavanagh et al., 2001; Guy, 2000; Li
et al., 2005; Stephensen et al., 1999; Velayudhan et al., 2003). One of
those genes, the coronavirus spike glycoprotein gene, codes for a
membrane-bound protein found on the surface of the virus that is
involved in attachment and entry into the host cell and therefore
plays a key role in host speciﬁcity (Holmes et al., 1993). In the group 3
coronaviruses, the spike glycoprotein is post-translationally cleaved
into an S1 subunit that contains the receptor binding domain and an
S2 subunit that is non-covalently bound to S1 and contains a
transmembrane domain that anchors the spike to the viral membrane.
Since IBV does not infect and cause disease in turkeys, we sequenced
the TCoV spike glycoprotein gene and found that it was not related to
IBV (GenBank accession nos. AY342356 and AY342357). More
recently, TCoV was reported to be closely related to IBV across the
entire genome with the exception of the spike gene, suggesting that
TCoV emerged from IBV (Cao et al., 2008; Gomaa et al., 2008) and Lin
et al. (2004) was the ﬁrst to suggest that recombination may account
for the unique spike gene in TCoV. However, the origin of the spike
gene sequence in TCoV is unknown.
In this study, we examine the pathogenicity and serologic
relatedness of different TCoV strains to better understand the disease
potential of this novel coronavirus. We identiﬁed genetic changes
associated with antigenic differences and with propagation in
embryonating eggs, and we analyzed the full-length genomic
sequences for several TCoV strains to reconstruct the genetic changes
that led to a host shift from chickens to turkeys and a pathogenicity
shift from the upper-respiratory tract to the enteric tract.
Results
In vivo experiments show that TCoV is pathogenic in poults,
nonpathogenic in chickens, and does not adapt to chickens
The TCoV strains used in this study (Table 1) were pathogenic for
1-day-old poults with diarrhea developing by 48 h post-inoculationTable 1
TCoV viruses examined in this study.
Isolate Location Year of isolation Accession numbers Virus titera
TCoV/VA-74/03 Virginia 2003 GQ427173 1×101.5
TCoV/TX-GL/01 Texas 2001 GQ427174 NDb
TCoV/TX-1038/98 Texas 1998 GQ427176 1×103
TCoV/IN-517/94 Indiana 1994 GQ427175 1×104
a Titers represent 50% poult infectious doses as determined in 1-day-old turkey
poults.
b ND=not done.(PI) and lesions in the gastrointestinal (GI) tract observed in most of
the birds by 72 and 96 h PI (Table 2). Lesions in the GI tracts consisted
of pale, ﬂaccid intestines with thin walls, and gaseous watery
contents. The ceca were bloated and ﬁlled with air and watery
contents. Real-time RT-PCR conducted on pooled GI tracts from poults
infected with the TCoV/TX-1038/98 strain had cycle threshold (Ct)
values of 21.7, 16.7, 20.1, and 37.6 at 24, 48, 72, and 96 h PI,
respectively (Table 2), indicating that the most virus (lowest real-
time RT-PCR Ct value) was detected in poults at 48 h PI. Based on this
data, the pooled GI tracts from poults given the other TCoV isolates
were examined at 48 h PI and the data are presented in Table 2.
No clinical signs of infection were observed in the upper-
respiratory tract or in the GI tract when the TCoV/TX-1038/98 or
the TCoV/TX-GL/01 strains were given to chickens. To determine if
TCoV could revert back to pathogenicity in chickens we passaged the
viruses in 1-day-old chicks by infecting the birds, re-isolating the virus
from the GI tract and giving it to additional 1-day-old chicks. No
clinical signs or lesions were observed when either virus was
passaged in 1-day-old chickens. The TCoV/TX-1038/98 virus was
detected in pooled GI tracts on day 3 for passages 1 and 2, and on day 5
for passage 3. The TCoV/TX-1038/98 virus could not be detected in
the pooled GI tracts from the fourth passage so the experiment was
terminated. The TCoV/TX-GL/01 virus was detected on day 3 after the
ﬁrst passage in 1-day-old SPF chickens but could not be detected in
the subsequent passage. No clinical signs, lesions, or virus were
detected in any of the contact exposed chickens for any of the
passages. Finally, the last virus-positive passage of TCoV/TX-1038/98
(third passage) and TCoV/TX-GL/01 (ﬁrst passage) in chickens were
examined for pathogenicity in 1-day-old poults and both were found
to induce clinical signs and lesions similar to the original virus before
passage in chickens (data not shown). The above data show that TCoV
does not adapt or revert to cause disease in chickens.Sequence analysis following virus passage in embryonating eggs reveals
changes in the spike gene
Wewanted to determine the capacity of this virus to change at the
molecular level. The spike glycoprotein gene was examined for
nucleotide and amino acid changes associated with passage of TCoV in
19-day-old embryonating turkey eggs. No sequence changes were
observed between the initial sequence determined for passage 1 and
passages 8, 10, 13, 14, 17, 18, 20, and 30 (Table 3). Between passages
30 and 40, we found 7 nucleotide changes in the spike glycoprotein
gene with 6 changes in S1 and 1 change in S2 (G2269A resulting in
amino acid change Val757Ile). Only two nucleotide changes, both in
S1, resulted in non-synonymous changes at residues Ser65Pro and
Asn84Lys. Between passages 40 and 49, we observed that 5 of the 6
changes detected in passage 30 were conserved, one reverted to the
original sequence, and there were 4 new changes. Between passages
49 and 50, we observed 7 conserved changes, 2 reversions, and 4 new
changes. Between passages 50 and 52, we observed 7 conserved
changes, 6 reversions to nucleotides observed in previous passages,
and 2 new changes.
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100 M.W. Jackwood et al. / Virology 398 (2010) 98–108Predicted residue changes in S1 between passages 30 and 40
included 2 changes (Ser65Pro and Asn84Lys); between passages 40
and 49, there were 1 conserved (Pro65), 1 reversion (Lys84Asn), and
3 new changes (Thr91Ser, Gly127Asp, Asn135His); between passages
49 and 50, there were 4 conserved (Pro65, Asn84, Ser91, and Asp127),
1 reversion (His135Asn), and 1 new change (Ile138Thr); and between
passages 50 and 52, there were 2 conserved (Pro65 and Asn84), 3
reversions (Ser91Thr, Asn135His, and Thr138Ile), and 2 new changes
(Asp127Ser and Gln239Arg). We sequenced all structural genes for
passages 8 and 40 of TCoV/TX-1038/98 and found only 1 nucleotide
change in a structural protein gene other than spike, which was a
synonymous change that occurred in the nucleocapsid gene (data not
shown).
We sequenced the spike glycoprotein gene from a second virus
(TCoV/TX-R/98) passaged in embryonating turkey eggs and found no
changes between passages 1 and 20 (Table 3). Between passages 20
and 24, two changes both non-synonymous occurred resulting in a
Gly139Asp and Gln180His change. The changes were conserved and
were the only changes observed through 30 passages. Taken together,
these data indicate that TCoV has the capacity to change through
replication, but the tolerated presumably advantageous mutations are
only observed following repeated passages in the host.
Real-time RT-PCR-based serum neutralization tests revealed the
presence of different serotypes of TCoV
To determine if TCoV has diverged to different serotypes, we
conducted virus neutralization (VN) testing. Because TCoV does not
produce lesions reliably when inoculated into embryonating eggs and
thereby cannot be used to evaluate the endpoint of a VN assay, we
used a real-time RT-PCR quantitative test to measure the neutralizing
activities of sera against TCoV in turkey poults (Bostic et al., 1999;
Saito et al., 2003; van Santen et al., 2004). Antiserum prepared against
3 different TCoV strains induced a statistically signiﬁcant reduction
(Student's t-test, Pb0.01) in virus replication in turkey poults as
determined by real-time RT-PCR when the homologous virus was
used in the assay. The antiserum titers representing the highest
dilution of serum that protected 50% of the poults from infection were
determined to be 64 for TCoV/VA-74/03, 256 for TCoV/TX-1038/98,
and 256 for TCoV/IN-517/94. When the Archetti and Horsfall (1950)
antigenic relatedness values were calculated using the homologous
and heterologous virus neutralization titers (Table 4), the relatedness
values were 2.2 for TCoV/VA-74/03 and TCoV/TX-1038/98, 1.6 for
TCoV/VA-74/03 and TCoV/IN-517/94, and 3.1 for TCoV/TX-1038/98
and TCoV/IN-517/94, indicating that the viruses were not serologi-
cally related.
Whole virus genome sequencing and comparative genomics show that
recombination led to the emergence of TCoV and different serotypes
result from molecular divergence within the spike gene
Strand displacement ampliﬁcation was successfully used to
amplify the viral genomic RNA from 4 different strains of TCoV, and
the cloned fragments were used to generate two different libraries forTable 4
Virus neutralization titers based on clinical signs in turkey poults and detection of virus
by the real-time RT-PCR test.
Antisera Virus
TCoV/VA-74/03 TCoV/TX-1038/98 TCoV/IN-517/94
TCoV/VA-74/03 64a 2 2
TCoV/TX-1038/98 4 256 2
TCoV/IN-517/94 2 32 256
a Highest dilution of antiserum that protected 50% of poults from infection as
determined by the real-time RT-PCR test and calculated using the Reed and Muench
test (Thayer and Beard, 2008).
Table 5
Genes and coding regions for 4 strains of turkey coronavirus examined in this study.
ORFa TCoV/VA-74/03 TCoV/TX-GL/01 TCoV/TX-1038/98 TCoV/IN-517/94
Size Size Size Size
Location ntb aac Location nt aa Location nt aa Location nt aa
5′ UTR 1–531 531 – 1–531 531 – 1–531 531 – 1–528 528 –
1a 532–12,357 11,844 3,947 532–12,381 11,850 3,949 532–12,384 11,853 3,950 529–12,387 11,859 3,952
1ab 532–20,321 19,790 6,596 532–20,339 19,808 6,602 532–20,339 19,808 6,602 529–20,345 19,817 6,605
Spike 20,345–24,025 3681 1,226 20,363–24,040 3678 1,225 20,363–24,037 3,675 1,224 20,369–24,049 3,681 1,226
3a 23,973–24,146 174 57 23,988–24,161 174 57 23,985–24,158 174 57 23,997–24,170 174 57
3b 24,146–24,340 195 64 24,161–24,355 195 64 24,158–24,352 195 64 24,170–24,364 195 64
Envelope 24,321–24,620 300 99 24,336–24,635 300 109 24,333–24,632 300 99 24,345–24,644 300 99
Membrane 24,622–25,293 672 223 24,637–25,314 678 225 24,634–25,305 672 223 24,646–25,317 672 223
X 25,294–25,578 285 94 25,315–25,599 285 94 25,306–25,590 285 94 25,318–25,602 285 94
5a 25,654–25,851 198 65 25,675–25,872 198 65 25,666–25,863 198 65 25,678–25,875 198 65
5b 25,848–26,096 249 82 25,869–26,117 249 82 25,830–26,108 279 92 25,872–26,120 249 82
Nucleocapsid 26,039–27,268 1230 409 26,060–27,289 1230 409 26,051–27,280 1230 409 26,063–27,292 1230 409
3′ UTR 27,269–27,771 502 – 27.290–27,619 330 – 27,281–27,782 502 – 27,293–27,665 373 –
a ORF=open reading frame.
b nt=nucleotide.
c aa=amino acid.
101M.W. Jackwood et al. / Virology 398 (2010) 98–108each virus. Sequences generated from both libraries resulted in 5 to
10× coverage of the genomes. The organization of the genome and
location and size of the open reading frames for TCoV/VA-74/03,Fig. 1. Neighbor-Joining method used to infer evolutionary history using full genomic seq
constructed from 1000 replicates (percentage of replicate trees in which associated strain
bottom of the ﬁgure.TCoV/TX-GL/01, TCoV/TX-1038/98, and TCoV/IN-517/94 are pre-
sented in Table 5. The genome sizes of TCoV/VA-74/03, TCoV/TX-GL/
01, TCoV/TX-1038/98, and TCoV/IN-517/94 are 27,771, 27,619,uence data of the available group 3 coronaviruses. The bootstrap consensus tree was
s clustered together are presented at nodes). The p-distance scale is presented at the
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102 M.W. Jackwood et al. / Virology 398 (2010) 98–10827,782, and 27,665 respectively. The order of the genes was the same
for all of the viruses examined; 5′ UTR-1a (1ab)-spike-3a-3b-
envelope-membrane-ORF X-5a-5b-Nucleocapsid-3′ UTR. The size of
the 5′ UTR was 531 nucleotides (nt) for each of the strains except for
the TCoV/IN-517/94 strain, which had a 528-nt 5′ UTR. The 3′ UTR
was 502 nt for TCoV/VA-74/03 and TCoV/TX-1038/98 whereas TCoV
TX-GL/01 and TCoV/IN-517/94 had a 330-nt and 373-nt 3′ UTR,
respectively. The ranges and sizes of the other genes were similar
among the 4 viruses (Table 5).
Whole genome alignments were generated and phylogenetic trees
were constructed with the Neighbor-Joining method, Minimum
Evolution method, Maximum Parsimony method, and UPGMA. All of
the trees had similar topography with signiﬁcant bootstrap support. A
tree containing the 4 TCoV isolates sequenced herein as well as other
available full-length genomes for the group 3 coronaviruses is shown
in Fig. 1. Three major clades are observed. The TCoV isolates form a
monophyletic group that nests within a lineage of IBV isolates. This is
supported by the percent similarity between the TCoV and IBV
isolates for the full-length genomes (Table 6, upper triangle), which
are greater than 86%. Three viruses, MuCoV HKU13, ThCoV HKU12,
and BuCoV HKU11, make up a second distinct lineage and a single
virus SW1 from a beluga whale separates into a third.
The sub-branch of the full genomic sequence tree containing the
TCoV isolates is shown in Fig. 2. Four genetic groups were observed
with TCoV/TX-GL/01 and TCoV/TX-1038/98 grouping together,
TCoV/MG10 and TCoV/VA-74/03 forming a second group, TCoV/IN-
517/94 and TCoV/540making up a third group, and TCoV/ATCC alone
in a fourth group. All viral genomes are at least 92.4% similar at the
nucleotide level. Similarity between TCoV groups at the nucleotide
level varies from 92.4% to 95.7% and within group similarity ranges
from 96.0% to 97.0% at the nucleotide level, which was the basis for
recognizing 4 groups.
Phylogenetic analysis of the protein sequences for spike, mem-
brane, RNA-dependent RNA polymerase (RdRp), nucleocapsid,
3CLpro, and helicase computed using Neithbor-Joining and the Nei-
Gojobori method are presented in Fig. 3 for TCoV/VA-74/03, TCoV/
TX-GL/01, TCoV/IN-517/94, TCoV/TX-1038/98, TCoV/MG10, TCoV/
540, TCoV/ATCC, and other representative group 3 coronaviruses
including IBV/Arkp11, beluga whale/CoV/SW1, ThrushCoV/HKU12,
and IBV/Mass41. Bayesian analysis andmaximum likelihoodmethods
for reconstructing evolutionary trees yield similar topologies (data
not shown). For all of the proteins, the beluga whale and thrush CoVs
do not cluster with the other viruses or with each other. In addition,
the TCoV's cluster with IBV/Mass41 and IBV/Arkp11 for all of the
proteins except spike. For the spike protein (Fig. 3d), the IBV isolates
clearly fall outside the cluster of TCoV viruses. This is supported by the
high percent similarities for the spike glycoproteins among TCoV
isolates, which are greater than 90%, whereas between TCoV and IBV
they are less than 36% (Table 6, lower triangle).
A codon-based Z-test for positive selection, MEGA4 (http://www.
megasoftware.net/index.html) was used to analyze the numbers of
non-synonymous and synonymous substitutions per site (dN/dS
ratio) in the spike gene and the test showed that positive selection
was occurring between the TCoV/TX-1038/98 and the TCoV/VA-74/
03 and TCoV/MG10/07 isolates (dN/dS=2.784 and 2.674, respec-
tively, and Pb0.003 and Pb0.004 respectively, Table 7).
To determine how TCoV isolates are related to IBV (IBV/Mass41
strain), an analysis using the SimPlot software (http://sray.med.som.
jhmi.edu/SCRoftware/simplot/) was conducted and the results are
shown in Fig. 4. Two major recombination events were observed, one
in the 3′ end of gene 1ab (at nucleotide 20,173, average for all TCoVs
examined) and one in the 3′ end of spike (at nucleotide 23,849,
average for all TCoVs examined). That result was supported by the
amino acid alignments (data not shown) used to construct the
phylogenetic trees shown in Fig. 3. Subsequently, BLASTN and BLASTP
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) analyses using all and parts
Fig. 2. Neighbor-Joining method used to infer evolutionary history using full genomic sequence data for available TCoV isolates. The bootstrap consensus sub-tree was constructed
from 1000 replicates (percentage of replicate trees in which associated strains clustered together are presented at nodes). The p-distance scale is presented at the bottom of the
ﬁgure. Different genetic groups are indicated at the right of the ﬁgure.
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GenBank or Swissprot databases were found. In addition, we
conducted a conserved domain search using RPS-BLAST (http://
www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi), which identiﬁed
conserved domains between TCoV spike and four group 1 corona-
viruses (canine coronavirus P36300, feline infectious peritonitis virus
Q66951, porcine enteric disease virus Q84712, and human corona-
virus-229E P15423) as well as IBV. Taken together, these data show
that recombination replaced the spike gene in IBV leading to the
emergence of TCoV, and that the spike glycoprotein gene subse-
quently underwent selection following cross-species transmission.
Discussion
A previously unrecognized group 3 coronavirus isolated from
turkeyswith enteric disease was found to be genetically similar to IBV,
a coronavirus that causes an upper-respiratory tract disease in
chickens (Cao et al., 2008; Lin et al., 2004). In this study, we
determined the full-length genome sequence of 4 different TCoV
strains and showed that the genomes were closely related to IBV
except in the spike glycoprotein gene. All 4 strains of TCoVwere found
to be pathogenic for 1-day-old turkeys but were not pathogenic for 1-
day-old chickens, indicating that the spike glycoprotein of this
coronavirus was responsible for the host shift from chickens to
turkeys and the pathogenicity shift from upper-respiratory disease to
enteric disease.
To determine if TCoV could adapt to cause disease in chickens, we
passaged two different strains of TCoV in 1-day-old chicks. Virus could
not be detected in the chicks following the 3rd passage of TCoV/TX-
1038/98 or after only 1 passage of TCoV/TX-GL/01. Furthermore,
TCoV was not transmissible among chickens since it was not detected
in any of the contact control birds. These data indicate that exposure/
passage of TCoV in chickens did not result in selection for changes
sufﬁcient to maintain infection and replication in chickens nor did it
lead to transmission of the virus among chickens. Based on this
ﬁnding and the observation that the TCoV spike glycoprotein only
bears about 35% similarity to the IBV spike glycoprotein, it appears
likely that a recombination event that replaced the spike glycoprotein
gene rather than selection of a virus subpopulation or genetic changes
was responsible for the emergence of TCoV. However, until a source
for the TCoV spike has been identiﬁed, alternate explanations for the
observed differences between TCoV and IBV spike should be
considered.
It is well known that many different serotypes of IBV exist, none of
which cross-protect (Cavanagh and Gelb, 2008; Fabricant, 1998).
Herein, three TCoV strains with genetically distinct spike glycoprotein
genes were examined by the real-time RT-PCR based serum
neutralization test and were found to be serologically unrelated.
Thus, it appears that the spike glycoprotein gene of TCoV has divergedto encode at least 3 different serotypes. These serologically distinct
strains of TCoV could be the result of adaptive evolution driven by the
host immune response. Adaptive evolution is the process by which
genetic changes in the viral genome leading to a more ﬁt virus
population become ﬁxed over time and has been reported for many
coronaviruses (Hasoksuz et al., 2007; Lee and Jackwood, 2001; Shi et
al., 2006; Tang et al., 2009; Zhang et al., 2006). Although all
coronaviruses undergo adaptive evolution, it is interesting that only
the group 3 coronaviruses, IBV and now based on our data TCoV, have
thus far been reported to diverge within the spike glycoprotein gene
to generate multiple different serotypes. Studies on divergent SARS-
CoVs showed that pseudoviruses expressing different human derived
SARS-CoV spike glycoproteins were all equally neutralized with the
exception of one virus (GD03), indicating that possibly two serotypes
may be present (Enjuanes et al., 2008). In addition, feline enteric
coronavirus (FECoV) has been reported to have two serologically
distinct types, but nearly all of the naturally occurring FECoV viruses
are type I (Tekes et al., 2008). It is not clear why divergence to
multiple different serotypes appears to be a unique characteristic for
at least two of the group 3 coronaviruses, but elucidating the
advantage of this phenomenon could lead to better vaccination
control strategies.
Typically, IBV is passaged in embryonating eggs to attenuate the
virus for use as a modiﬁed live vaccine in chickens. To determine
structural protein sequence changes associated with multiple pas-
sages in eggs, we passaged two different TCoV strains in 18-day-old
embryonating turkey eggs and found that few or no amino acid
changes were observed for the ﬁrst 20 to 30 passages (Table 3).
Between 30 and 52 passages in embryonating eggs, we found 4 amino
acid changes that became ﬁxed, 3 that reverted, and 1 that was
variable in the S1 subunit of the spike glycoprotein. No non-
synonymous changes and only 1 synonymous change (nucleocapsid
gene) were observed in the other structural proteins of the virus. It is
not clear why no changes were observed in the virus for the earlier
passages in embryonating eggs. Coronaviruses have a high mutation
rate that has been estimated to be 1×10−3 synonymous substitu-
tions/site/year (Holmes, 2009). Studies on the genetic changes
associated with adaption of the SARS-CoV to palm civets and
subsequently to humans showed that mutations were being ﬁxed at
a high rate following cross-species transmission then slowed in the
later stages of the epidemic (Kan et al., 2005; Song et al., 2005).
Assuming the evolutionary dynamics of coronaviruses result in an
increase in observed sequence variation when introduced into a new
host, one would expect to see a high number of changes in the ﬁrst
few passages in embryonating eggs. It is possible that changes
occurred in the 1a and 1ab polyprotein genes since we did not
examine that area of the genome, but it is well known that the highest
rate of change is observed in the spike glycoprotein because it is
involved in attachment and entry into the host cell, so some level of
Fig. 3. Phylogenetic relationships of virus proteins. Phylogenetic trees showing amino acid sequence relatedness computed using Neighbor-Joining and the Nei-Gojobori method. (a)
Main protease (3CLpro) coding region (residues 2778-3084 in the 1ab protein). (b) RNA-dependent RNA polymerase (RdRp) coding region (residues 3927-4866 in the 1ab protein).
(c) Helicase coding region (residues 4867–5465 in the 1ab protein). (d) Spike glycoprotein. (e)Membrane glycoprotein. (f) Nucleocapsid protein. Viruses included in the analysis are
TCoV/74 (GQ427173), TCoV/TX-GL (GQ427174), TCoV/TX-1038 (GQ427176), TCoV/IN-517 (GQ427175), TCoV/MG10 (EU095850), TCoV/540 (EU022525), TCoV/ATCC
(EU022526), IBV/Ark (EU418976), IBV/Mass41 (AY851295), SW1 (NC010646), and ThCoV (FJ376621). The amino acid sequences were aligned with ClustalW (MEGA 4.0.2,
Tamura et al., 2007), and the evolutionary distances are shown for each of the trees. Residue positions listed above are relative to the TCoV/TX-GL/01 strain.
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We did not examine the sequence of the TCoV strains prior to the ﬁrst
passage in embryonating eggs because there was not enough of the
virus present. Therefore, it is possible that selection of a viral
subpopulation following only one passage in embryonating eggs
could have occurred leading to a reasonably ﬁt population of viruses
that then underwent adaptive evolution. In a previous study, we
found that a more ﬁt subpopulation of an embryonating egg-adapted
vaccine virus for IBV was selected after only one passage in chickens
(McKinley et al., 2008). Since deleterious as well as advantageouschanges can occur with extremely high mutation rates, such as those
rates found in coronaviruses, it is possible that minor more ﬁt
coronavirus subpopulations would then take several passages before
becoming the predominant species (Holmes, 2009). It is interesting to
note that attenuation of pathogenic IBV strains by passage in
embryonating eggs takes more than 50 passages and can take up to
75 or 100 passages (Jackwood et al., 2003).
Strand displacement ampliﬁcation was used to randomly amplify
the viral genomic RNA of 4 TCoV strains and two cDNA libraries for
each virus were produced. The genome organization, location and size
Table 7
Codon-based Z-test for positive selectiona in the spike gene.
TCoV/TX-1038/98 TCoV/IN-517/94 TCoV/TX-GL/01 TCoV/VA-74/03 TCoV/MG10/07 TCoV/MN-ATCC/69 TCoV/IN-540/94
TCoV/TX-1038/98 – −0624 −3.299 2.784 2.674 −3.690 −2.036
TCoV/IN-517/94 1.000 – −2.862 −2.176 −2.258 −4.532 −2.842
TCoV/TX-GL/01 1.000 1.000 – −2.791 −2.850 −4.635 −2.847
TCoV/VA-74/03 0.003 1.000 1.000 – 1.032 −3.786 −2.891
TCoV/MG10/07 0.004 1.000 1.000 0.152 – −3.743 −2.953
TCoV/MN-ATCC/69 1.000 1.000 1.000 1.000 1.000 – −4.744
TCoV/IN-540/94 1.000 1.000 1.000 1.000 1.000 1.000 –
a The probabilities (P) of rejecting the null hypothesis of strict neutrality (dN=dS) in favor of the alternative hypothesis (dNNdS) is shown below the diagonal. Values of Pb0.05
are considered signiﬁcant. The test statistic values shown above the diagonal are the numbers of synonymous dS and non-synonymous dN substitutions per site, respectively. The
variance of the difference was computed using the bootstrap method (1000 replicates).
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previously published data for TCoVs (Cao et al., 2008; Gomaa et al.,
2008; Lin et al., 2004). Two different alignment methods and four
different methods of constructing phylogenetic trees, resulted in trees
with nearly identical topology. When other available group 3
coronavirus full-length genomes were examined (Fig. 1), three
major clades were observed supporting recently published data
indicating that the group 3 coronaviruses can be divided into three
subgroups (Woo et al., 2009b); subgroup 3a containing TCoV and IBV
isolates, subgroup 3b containing viruses isolated from a bulbul, a
thrush, and a munia, and subgroup 3c containing a virus isolated from
a beluga whale (SW1). We further divide the TCoV isolates into 4
genetic groups (Fig. 2), and conﬁrmed that viruses from 3 of the
genetic groups represent different serotypes (Table 4).
The topology of the spike glycoprotein trees compared to other
protein coding sequences (Fig. 3) showed the TCoV spike glycoprotein
to be clearly different from that of IBV. Recombination detection
analysis on TCoV isolates (Fig. 4) showed that recombination occurred
in the 3′ end of gene 1ab (nt. position 20,173) and at about 177
nucleotides from the 3′ end of spike (nt. position 23,849), essentially
inserting a different spike gene into TCoV. That result was supported
by the amino acid alignments used to construct the phylogenetic
relationships of virus proteins shown in Fig. 3. Similarities between
spike glycoprotein sequences and the locations of the crossover sites
among TCoVs isolated over time indicate that this was a one-time
event, which led to the emergence of TCoV from its closest IBV
ancestor. This is the ﬁrst evidence that recombination in corona-Fig. 4. Simplot analysis of full-length genomic sequence for IBV/Mass 41, TCoV/VA-74/0
between nucleotides 20,173 and 23,849. The query sequence is TCoV/VA-74/03. Bars at the
and nucleocapsid (N).viruses directly led to cross-species transmission and the emergence
of a new disease. Although SARS-CoV was shown to be a recombinant
virus, this recombination event was reported to have occurred before
the cross-species spread to intermediate hosts (raccoon dog, Nycter-
eutes procyonoides and Asian palm civet, Paradoxurus hermaphroditus)
and ultimately to humans (Hon et al., 2008). Therefore, recombination
is likely not the direct cause of emergence of SARS.
Examining the dN/dS ratios for the spike gene in TCoV showed that
positive selection was occurring between viruses isolated in 1998 and
2003/2007, after the emergence of the disease in turkeys. Similar to
what was observed for the emergence and evolution of the SARS-CoV,
a high rate of molecular evolution is observed when viruses switch
hosts (Song et al., 2005). This result appears to contradict our
observation above that little or no change in the structural proteins of
TCoV occurs during the ﬁrst 30 to 50 passages in eggs. Perhaps a low
rate of molecular evolution occurred in the eggs because the cells
lining the GI tract of an 18-day-old turkey embryo are not
substantially different from the cells in the GI tract of a poult or
because there are other yet to be identiﬁed constraints on these
molecules.
We conducted BLAST analyzes on the nucleic acid and amino acid
sequences within the recombination sites as well as on different
overlapping segments of the TCoV spike sequence but could not ﬁnd
similar sequences in any of the databases examined. Although the
source of the genetic material making up the TCoV spike is not known
at this time, it is likely from another coronavirus because the makeup
of the TCoV spike resembles that of other coronavirus surface3, TCoV/TX-GL/01, TCoV/IN-517/94, and TCoV/TX-1038/98 showing recombination
top represent relative position of the coding regions for 1a, 1ab, spike, membrane (M),
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fusion peptide, heptad repeats, and a transmembrane domain (Bosch
et al., 2003). Our data clearly show that the mechanism driving cross-
species transmission in this group 3 coronavirus was a double
crossover event that replaced the spike gene, followed by adaptive
evolution to create different serotypes. Thus, it appears that
emergence of new coronaviruses and coronaviral diseases can occur
through recombination as well as selection upon mutations (Holmes,
2009; Holmes and Rambaut, 2004). Preventing the emergence of new
coronaviruses therefore requires that we identify and limit exposure
to reservoirs of coronaviruses that can serve as a source of genetic
material for emerging viruses. Elucidating the molecular events
associated with cross-species transmission and pathogenicity shifts
provides valuable insight into the mechanisms behind coronaviral
evolutionary biology.With that knowledge, wewill be able to develop
better control measures that prevent vaccine failures, antiviral drug
resistance, and the emergence of new coronaviral diseases in animals
and humans.
Materials and methods
Viruses and speciﬁc serotyping antisera
Four isolates of TCoV (Table 1.) designated TCoV/VA-74/03, TCoV/
TX-GL/01, TCoV/TX-1038/98, and TCoV/IN-517/94 (Lin et al., 2002)
were obtained from Mr. Tom Hooper (Purdue University, West
Lafayette, IN, USA). The viruses were propagated in 1-day-old speciﬁc
pathogen-free (SPF) turkeys and in 18- to 22-day-old embryonating
turkey eggs (a gift from Dr. M. J. Pantin-Jackwood, Southeast Poultry
Research Laboratory, USDA, ARS, Athens, GA and from Dr. Y. M. Saif,
FAHRP, OARDC, The Ohio State University, Wooster, OH). When
viruses were propagated in 1-day-old turkeys, the birds were
inoculated with 100 μl of virus per os. The birds were necropsied
48 h post-inoculation and the gastrointestinal (GI) tracts were
harvested and frozen at –80 C. When virus was propagated in
embryonating turkey eggs, the chorioallantoic sac was inoculated
with 100 μl of virus. The eggs were incubated for 48 h then the GI
tracts of the embryos were extracted and frozen at –80 C. The frozen
GI tracts from embryos and poults were thawed, homogenized,
clariﬁed by low speed centrifugation (200×g for 10 min), and ﬁltered
through a 0.8-μm ﬁlter then a 0.22-μm ﬁlter (Millipore, Bedford, MA).
Serotyping antiserum was prepared against each of the TCoV
isolates in SPF turkeys using previously publishedmethods with a few
modiﬁcations (Gelb and Jackwood, 2008). Brieﬂy, 2-week-old SPF
turkeys (Southeast Poultry Research Laboratory, Athens, GA) held in
positive pressure Horsfal isolation units were given at least 1×103
50% poult infectious doses of virus per os. Two weeks post-exposure,
the birds were injected intravenously with 1×103 50% poult
infectious doses and serum was collected 2 weeks post intravenous
injection. The serum was heat inactivated at 56 C for 30 min and
stored at –20 C.
Pathogenicity testing in turkeys and chickens
One-day-old turkeys were given 100 μl of TCoV per os then
examined for clinical signs and lesions in the GI tract at 24, 48, 72, and
96 h after exposure. Each of the TCoV isolates TCoV/VA-74/03, TCoV/
TX-GL/01, TCoV/IN-517/94, and TCoV/TX-1038/98 were given to 4
poults per sample time for each virus. In addition, the GI tracts for
TCoV/TX-1038/98 were harvested at 24, 48, 72, and 96 h PI, pooled
per sample time, and frozen at –80 C. The GI tracts of all the other
viruses were harvested at 48 h PI, pooled and frozen at −80 C. The
pooled GI tracts were processed for RNA extraction and real-time RT-
PCR as described below.
Ten, 1-day-old SPF chickens (Charles River Laboratories, Inc.
SPAFAS, North Franklin, CT) were each given 100 μl of either theTCoV/TX-1038/98 virus or the TCoV/TX-GL/01 virus per os and
examined daily for clinical signs of disease. In addition, 3 non-
inoculated contact exposed chickens were included to determine
transmissibility. At 3 and 5 days PI, 3 exposed birds and 1 contact
control bird and at 10 days PI, 4 exposed birds and 1 contact control
bird for each virus were killed and examined for lesions in the GI tract.
The GI tracts were harvested, pooled per virus/treatment/necropsy
day, and frozen at –80 C. The pooled GI tracts were thawed,
homogenized, clariﬁed by low speed centrifugation (200×g for
10 min), and ﬁltered through a 0.8-μm ﬁlter then a 0.22-μm ﬁlter
(Millipore) to prepare inoculums for further passage in chicks. Real-
time RT-PCR was used to verify that virus was present in the
inoculums before passing the virus in 10 additional infected and 3
contact exposed 1-day-old chickens. The virus was passed until it
could no longer be recovered from the chickens. To verify the viruses
were still pathogenic for poults, the last passage of the viruses
reisolated from the chickens was given to ten 1-day-old turkeys. The
birds were examined for clinical signs daily then necropsied at 5 days
PI and examined for lesions.
Real-time RT-PCR-based serum neutralization test
The serum neutralization test was conducted using the constant-
virus diluted-serum (beta) method as previously described (Gelb and
Jackwood, 2008). Ten-fold serial dilutions of the viruses were titrated
in 1-day-old turkeys by inoculating 5 poults per dilutionwith 100 μl of
virus per os. The birds were necropsied 48 h post-inoculation and the
gastrointestinal (GI) tracts were examined for lesions. One-hundred,
50% poult infectious doses of virus were mixed with an equal volume
of serotyping antisera diluted 2-fold in PBS (pH 7.4). The mixtures
were incubated at room temperature for 30 min then 200 μl was
inoculated per os into 5 poults per dilution. Poults were held in
isolation units for 48 h then necropsied and the GI tracts were
examined for signs of TCoV infection, harvested, and processed as
described above for the real-time RT-PCR serum neutralization test.
Positive and negative control groups of 5 poults each were also
maintained.
A real-time RT-PCR quantitative analysis on the processed GI tracts
was conducted as previously described (Callison et al., 2006) and used
to evaluate the neutralizing immune reactions (Bostic et al., 1999;
Saito et al., 2003; van Santen et al., 2004). Brieﬂy, RNA was extracted
using the High Pure RNA Isolation Kit (Roche, Indianapolis, IN) and
the real-time RT-PCR was conducted in a SmartCycler (Cepheid,
Sunnyvale, CA). Forward primer (IBV5′GU391 5′-GCTTTTGAGCC-
TAGCGTT-3′), reverse primer (IBV5′GL533 5′GCCATGTTGTCACTGTC-
TATTG-3′), and Taqman® dual-labeled probe (IBV5′G probe 5′-FAM-
CACCACCAGAACCTGTCACCTC-BHQ1-3′) were used to amplify and
detect a 143-bp fragment at the 5′ end of the TCoV genome. A
standard curve based on 10-fold serial dilutions of each TCoV isolate
titrated in poults was developed and used to calculate the amount of
TCoV genomes present in each GI tract from poults in the
neutralization test. The neutralization assay data was tested using
the null hypothesis and Student's t-test statistic as previously
described (van Santen et al., 2004). Antibody titers were recorded
as the highest serum dilution that neutralized the virus (negative real-
time RT-PCR test) in at least 50% of the samples collected within a
group as calculated by the Reed and Muench Test (Thayer and Beard,
2008). Antigenic relatedness values were calculated using the Archetti
and Horsfall (1950) test.
Sequence analysis following passage in embryonating eggs
The genes encoding structural proteins of TCoV/TX-1038/98 virus
passages 8 and 40 and TCoV/TX-GL/01 virus passages 11 and 30 in
embryonating turkey eggs were sequenced to identify sequence
changes. Amplicons from RT-PCR reactions using speciﬁc overlapping
Table 8
Primer pairs used in RT-PCR reactions to sequence the 3′ end of TCoV isolates passaged
in embryonating eggs.
Primer pairs Locationsa Sequence
TCoV S1 5′ 20,338–20,358 5′-AAGAGTGGCAAGTTGTTAGTT-3′
TCoV S1 3′ 22,017–22,037 5′-CCATAGCTGCAAATAGACCTA-3′
TCoV 1511 5′ 21,882–21,901 5′-CTGCATCTTGTCGGTTAGCC-3′
TCoV 3809 3′ 24,179–24,198 5′-TGCTCACCAGTTTCAATAAT-3′
TCoV 3565 5′ 23,936–23,956 5′-ACTTTTGATAATGATGTGGTG-3′
TCoV 5538 3′ 25,963–25,983 5′-GCTCTGCTTGTCCTGCTTTGT-3′
TCoV 5046 5′ 25,378–25,397 5′-AAGAGTATTTATTTTGAGGA-3′
Oligo-dT 3′ 27,621–27,638 5′-TTTTTTTTTTTTTTTTTT-3′
a Primer pair nucleotide locations are based on the sequence for TCoV/TX-GL/01
(accession number GQ427174).
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previously described (Lee, Hilt, and Jackwood, 2000) and sequenced
directly at the Molecular Genetics Instrumentation Facility (Univer-
sity of Georgia, Athens, GA) with the Prism( DyeDeoxy terminator
cycle sequencing kit according to the manufacturer's recommenda-
tions (Perkin-Elmer, Foster City, CA). The sequences were assembled
using SeqMan Pro, and genome annotation was conducted with
SeqBuilder (DNASTAR, Inc., v.8.0.2, Madison, WI). Nucleotide and
deduced amino acid alignments were assembled using Clustal W in
the MegAlign program (DNASTAR, Inc.).
Whole genome nucleotide and deduced amino acid sequence analysis
Viral RNA was puriﬁed with the High Pure RNA extraction kit
(Roche Diagnostics Corporation, Indianapolis, IN) and used directly in
the ampliﬁcation reaction.
The TaKaRa RNA LA PCR kit (Takara Bio Inc., Otsu, Shiga, Japan),
which utilizes avian myeloblastosis virus (AMV) reverse transcriptase
(RT), was used in a strand displacement ampliﬁcation reaction to
randomly amplify the viral genomic RNA. A random ampliﬁcation
primer (5′-AGCGGGGGTTGTCGAATGTTTGANNNNN-3′) and an am-
pliﬁcation primer is (5′AGCGGGGGTTGTCGAATGTTTGA-3′) were
used in the reaction.
A GeneAmp System 9600 thermocycler (Perkin-Elmer Applied
Biosystems, Foster City, CA) was used for the RT-PCR reactions, which
included an RNA denaturing step at 65 C for 1min followed by 30 C for
10 min then 42 C for 60 min. The RT reaction was heat denatured at
99 C for 5 min then cooled to 5 C. The PCR ampliﬁcation reaction was
30 cycles of 94 C for 30 s, 60 C for 30 s, and 72 C for 3 min.
The expected result is a smear of ampliﬁed DNAs that range in size
from 500 to 1500 bp in length. The ampliﬁed products were gel
puriﬁed, cloned using the TOPO TA cloning kit (Invitrogen, Carlsbad,
CA) and sequenced.
Plasmid DNA from the libraries of cloned cDNA fragments for each
virus was isolated using an alkaline lysis method modiﬁed for the 96-
well format and incorporating both Hydra and Tomtek robots (http://
www.intl-pag.org/11/abstracts/P2c_P116_XI.html). Cycle sequenc-
ing reactions were performed using the BigDye™ Terminator® Cycle
Sequencing Kit Version 3.1 (Applied Biosystems, Foster City, CA) and
MJ Research (Watertown, MA) thermocyclers. Finished reactions
were ﬁltered through Sephadex ﬁlter plates into Perkin-Elmer
MicroAmp Optical 96-well plates. A 1/12-strength sequencing
reaction on an ABI 3730 was used to sequence each clone from both
the 5′ and 3′ ends. Each viral genome was shotgun sequenced to 10×
coverage.
Chromatogram ﬁles and trace data were read and assembled using
SeqMan Pro, and genome annotation was conducted with SeqBuilder
(DNASTAR, Inc.). Whole genome alignments were generated and
phylogenetic trees were constructed with the Neighbor-Joining
method, Minimum Evolution method, Maximum Parsimony method,
and UPGMA with 1000 bootstrap replicates (MEGA4, http://www.megasoftware.net/index.html) (Tamura et al., 2007). To reconstruct
evolutionary trees, maximum likelihood (Tree-Puzzle, http://www.
tree-puzzle.de/) and Bayesian analysis (BEAST 1.4, http://beast.bio.
ed.ac.uk/) were conducted. A codon-based test of positive selection
(Z-test, MEGA4) was used to analyze the numbers of non-synony-
mous and synonymous substitutions per site (dN/dS ratio). To
determine how TCoV isolates are related to IBV (IBV/Mass41 strain),
an analysis using the SimPlot software (http://sray.med.som.jhmi.-
edu/SCRoftware/simplot/) was conducted with TCoV/VA-74/03 as
the query sequence and using a 400-bp window and a 100-bp step.
Finally, BLASTN and BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi)
analyses using all and overlapping (100 nt and 33 amino acid)
fragments of the recombined region were conducted using the
GenBank or Swissprot databases.
GenBank accession numbers
Sequences generated in this study for TCoV were submitted to
GenBank and assigned the following accession numbers: TCoV/VA-
74/03 (GQ427173); TCoV/TX-GL/01 (GQ427174); TCoV/TX-1038/
98 (GQ427176); TCoV/IN-517/94 (GQ427175); TCoV/TX-1038/98
Pass 40 (GQ469644); TCoV/TX-1038/98 Pass 49 (GU213199); TCoV/
TX-1038/98 Pass 50 (GU213200); TCoV/TX-1038/98 Pass 52
(GU213201); TCoV/TX-R/98 Pass 24 (GU213202). Accession numb-
ers for reference sequences used in this study are TCoV/MG10
(EU095850); TCoV/IN-540/94 (EU022525); TCoV/MN-ATCC
(EU022526); TCoV/Canada-MG10 (EU095850); IBV/CK/Mass 41
(AY851295); IBV/CK/Arkp11 (EU418976); IBV/CK/Arkp101
(EU418975); IBV/CK/Beaudette (NC001451); IBV/CK/H120
(FJ888351); IBV/CK/CA99 (AY514485); IBV/CK/CH/LSD/051
(EU637854); IBV/CK/SAIBK (DQ288927); IBV/CK/BJ (AY319651);
Partridge/GD/S14/03 (AY646283); IBV/CK/A2 (EU526388); beluga
whale/CoV/SW1 (NC010646); ThrushCoV/HKU12 (FJ376621);
MuniaCoV/HKU13 (FJ376622); Bulbul/CoV/HKU11 (FJ376619).
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